Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients-Reference-Cited by-同舟云学术

Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients

Published:2022-08 Issue:8 Volume:22 Page:2083-2088
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Salerno David M.^ORCID,Jennings Douglas L.^ORCID,Lange Nicholas W.^ORCID,Kovac Danielle (Bley),Shertel Tara,Chen Justin K.^ORCID,Hedvat Jessica^ORCID,Scheffert Jenna,Brown Jr Robert S.,Pereira Marcus R.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.17027

Reference15 articles.

1. COVID-19 in solid organ transplant recipients: initial report from the US epicenter;Pereira;Am J Transplant.,2020

2. Maggiore U, Riella LV, Azzi J, Cravedi P. Mortality in solid organ transplant recipients with COVID-19: more than meets the eye. Am J Transplant. doi:10.1111/ajt.16942

3. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2;Liu;Nature.,2022

4. Early remdesivir to prevent progression to severe Covid-19 in outpatients;Gottlieb;N Engl J Med.,2022

5. An oral SARS-CoV-2 M;Owen;Science.,2021

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus;Frontiers in Pharmacology;2024-06-19

2. COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan;Clinical and Experimental Medicine;2024-06-10

3. Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19;Frontiers in Medicine;2024-04-03

4. Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review;Expert Opinion on Drug Metabolism & Toxicology;2024-04-02

5. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19;Transplant International;2024-03-26